血管紧张素抑制剂对腹膜透析患者生存率及技术生存率的影响(2)
第1页 |
参见附件。
总之,笔者认为,血管紧张素抑制剂的使用可以改善腹膜透析患者生存率和技术生存率。但由于回顾性研究的局限性以及样本量的问题,研究结果可能存在一定的偏倚,需要进一步大规模、前瞻性的研究结果证实。
参考文献
[1]Ondocin P T,Narsipur S S.Influence of angiotensin converting enzyme inhibitor treatment on cardiac autonomic modulation in patients receiving haemodialysis[J].Nephrology,2006,11(6):497-501.
[2]钟慧沙,朝晖,崔天蕾,等.依贝沙坦对维持性腹膜透析患者残存肾功能的保护作用[J].中华肾脏病杂志,2007,23(7):413-416.
[3]孙晶,张虹,于克洲.肾素血管紧张素系统抑制剂对长期腹膜透析患者腹膜纤维化和残余肾功能的作用[J].中国血液净化,2010,9(3):152-155.
[4]Taner B,Unsal I A,Koc I Y.The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients[J].Clinical,2012,67(8):877-883.
[5]Kolesnyk I,Noordzij M,Dekker F W,et al.A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients[J].Nephrol Dial Transplant,2009,24(1):272-277.
[6]Fang W,Oreopoulos D G,Bargman J M.Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis[J].Nephrol Dial Transplant,2008,23(11):3704-3710.
[7]Devrim B,Pinar C,Savas S,et al.The effects of enin- angiotensin system inhibition on regression of encapsulating peritoneal sclerosis[J].Peritoneal Dialysis International,2008,28(5):S38-S42.
[8]Denise E S,Inna K,Mario R K,et al.Use of angiotensinⅡ inhibitors in patients that develop encapsulating peritoneal sclerosis[J].Peritoneal Dialysis International,2010,6(30):656-659.
(收稿日期:2013-10-20) (编辑:何玉勤)
您现在查看是摘要介绍页,详见PDF附件。